What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France.
Head and neck cancers (HNC) have a poor prognosis and a long treatment delay may have a negative impact on this. Some studies have investigated the determinants of this delay but not in the general population and rarely taking into account socio-economic factors. A high-resolution population-based study about cancer management was conducted, using registries in the north-west of France, on HNC diagnosed between 2008 and 2010. The median time between diagnosis and multidisciplinary team meeting (DMI) (N = 1631) was 14 days (Q1: 7 to Q3: 26). The median time between diagnosis and first treatment (DTI) (N = 1519) was 35 days (Q1: 21 to Q3: 54). When the first treatment was radiotherapy, the interval was 54.5 days (Q1: 40 to Q3: 71). In multivariate analysis, DTI was associated with the type of first treatment and place of treatment. For advanced stage HNC, DTI was associated with comorbidities, topography of the cancer and socio-economic status, underprivileged patients being treated later than privileged ones. Given the French governmental cancer plans which set out to coordinate care pathways via nursing coordinators and to improve the availability of radiotherapy, the waiting times observed in this study still seem long. The optimal care pathway should include adapted social management but the DTI was still longer for underprivileged patients.
Registre général des tumeurs du Calvados, Centre F Baclesse, 14000, Caen, France.|U1086 Inserm, Université Caen Basse Normandie, "Cancer et prévention", Centre F Baclesse, 14000, Caen, France.
Anne-Valerie
AV
Guizard
U1086 Inserm, Université Caen Basse Normandie, "Cancer et prévention", Centre F Baclesse, 14000, Caen, France.|Pôle de Recherche, Centre Hospitalo-universitaire de Caen, 14000, Caen, France.
Olivier
O
Dejardin
U1086 Inserm, Université Caen Basse Normandie, "Cancer et prévention", Centre F Baclesse, 14000, Caen, France.
Ludivine
L
Launay
Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, 50100, Cherbourg-Octeville, France.
Simona
S
Bara
Registre du cancer de la Somme, Hôpital Nord, 80054, Amiens, France.
Bénédicte
B
Lapôtre-Ledoux
U1086 Inserm, Université Caen Basse Normandie, "Cancer et prévention", Centre F Baclesse, 14000, Caen, France.|Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, 14000, Caen, France.
Emmanuel
E
Babin
U1086 Inserm, Université Caen Basse Normandie, "Cancer et prévention", Centre F Baclesse, 14000, Caen, France.|Pôle de Recherche, Centre Hospitalo-universitaire de Caen, 14000, Caen, France.
Guy
G
Launoy
Registre général des cancers de Lille et sa région, GCS "Centre de Référence Régional en Cancérologie", CHRU de LILLE, Hôpital Calmette, Pavillon Breton, Boulevard du Professeur Jules Leclercq, 59037, Lille Cedex, France. kligier@registrecancers59.fr.
Karine
K
Ligier
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000628:therapy*; D019468:Disease Management; D005260:Female; D005602:France; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D012042:Registries; D012959:Socioeconomic Factors; D013997:Time Factors; D061665:Time-to-Treatment / Q000706:statistics & numerical data*
Head and neck cancer; Population-based study; Treatment delay; Waiting time